Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Liposarcoma × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Prostate Cancer Metastatic 1 Liposarcoma 1

Interventions

Ifosfamide 6 Doxorubicin 6 brostallicin 2 Trabectedin 2 Radiotherapy, Conformal 2 Filgrastim 2 perifosine 1 pegfilgrastim 1 indolepropanol phosphate 1 exatecan 1 cabazitaxel 1 X-Rays 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Radiotherapy 1 Observation 1 Neoadjuvant Therapy 1 Mass Spectrometry 1 Glutamine 1 Combined Modality Therapy 1 Chromatography, High Pressure Liquid 1 Chemotherapy, Adjuvant 1 Biopsy 1 BI 2536 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01913652 2021-09-14

Ph II Cabazitaxel DD Liposarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡